Use of Medroxyprogesterone Acetate as a Contraceptive in conjunction with Early Postpartum Rubella Vaccination
- 24 November 1973
- Vol. 4 (5890), 443-446
- https://doi.org/10.1136/bmj.4.5890.443
Abstract
During a 12-month period 170 women received early postpartum rubella vaccination. An injectable “depot” progestogen was given to each of these patients for contraceptive purposes at the same time as the vaccine was administered. Subsequent observations showed that the progestogen was effective as a contraceptive in this context and that it did not appear to affect the immune response of the patients to the vaccine.Keywords
This publication has 9 references indexed in Scilit:
- Rubella Vaccination and Termination of PregnancyBMJ, 1972
- IgG, IgA and IgM responses in acute rubella determined by the immunofluorescent techniqueEpidemiology and Infection, 1972
- Long‐Term Use of Depot Medroxy Progesterone Acetate as a ContraceptiveActa Obstetricia et Gynecologica Scandinavica, 1972
- Experience with Depo-Medroxyprogesterone Acetate (Depo-Provera) as a Contraceptive AgentPublished by Wiley ,1972
- Use of injectable contraceptive immediately post partum.1971
- RISK OF EARLY POST-PARTUM PREGNANCY IN CONTEXT OF POST-PARTUM VACCINATION AGAINST RUBELLAThe Lancet, 1971
- Vaccination of women with the Cendehill strain of rubella virus.1971
- Isolation of Rubella Virus from Abortion MaterialBMJ, 1970
- Continuous rabbit kidney cell cultures in the diagnosis of rebella infections.1965